1. 郗彦凤(通讯作者)Effective Combination of Targeted Therapies with SonodynamicTreatment for Use in Exploring Differences in Therapeutic Efficacy across Organelle Targets. Mol. Pharmaceutics 2024, 21, 2, 760–769 影响因子:4.5 2. 郗彦凤(通讯作者)Clinicopathological and genomic characterization of intestinal adenosquamous carcinoma. Br J Surg,2024,111(10)影响因子:8.7 3. 郗彦凤(通讯作者)The splicing factor SF3B1 confers ferroptosis resistance and promotes lung adenocarcinoma progression via upregulation of SLC7A11. Cancer Gene Ther. 2024 Oct;31(10):1498-1510. 影响因子:4.8 4. 郗彦凤(通讯作者)Exploring the expression and clinical significance of the miR-140-3p-HOXA9 axis in colorectal cancer.Cancer Res Clin Oncol.2023,149(13):11397-11410影响因子:2.7 5. 郗彦凤(通讯作者)CDKN2A promoter methylation enhances self-renewal of glioblastoma stem cells and confers resistance to carmustine. Mol Biol Rep,2024,51(1):385.影响因子:2.6 6. 郗彦凤(通讯作者)Differential expression of BCL11b and CDKN2A in CD30-positive peripheral T cell lymphoma Retrospective study Observational Study (2023) 102:46 1-7 7. 郗彦凤(通讯作者)结直肠癌组织中肿瘤血管正常化的研究进展.中华病理学杂志.2024,53(8): 135-139. 8. 郗彦凤(通讯作者)消皮素家族介导细胞焦亡在结直肠癌中的研究进展. 中华实验外科杂志2023.40(11): 2415-2419 9. 郗彦凤(通讯作者)非小细胞肺癌PD‑L1表达临床检测中国专家共识(2023版)中华病理学杂志.2024,53(3): 121-129. 10. 郗彦凤(通讯作者)非小细胞肺癌分子病理检测临床实践指南 11. (2024版)中华病理学杂志.2024,53(10): 981-994. |